Medicare Enrolled
Dr. Loren Novak, D.O.
Family Medicine · Vista, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Novak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Novak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Novak
Dr. Loren Novak is a family medicine specialist in Vista, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Novak performed 4,194 Medicare services across 1,253 unique beneficiaries.
Between the years covered by Open Payments, Dr. Novak received a total of $16,138 from 79 pharmaceutical and/or device companies across 746 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Novak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$16,138 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,194
Medicare services
Top 4% in CA for family medicine
1,253
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~221 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,160 | $18 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
853 | $95 | $286 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
175 | $8 | $15 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
147 | $138 | $263 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
110 | $77 | $218 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
105 | $1 | $20 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
99 | $68 | $193 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
98 | $147 | $394 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
82 | $33 | $57 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
80 | $72 | $140 |
| Nursing facility discharge management, more than 30 minutes This service involves care coordination and management activities performed by a healthcare professional to prepare a patient for discharge from a nursing facility. It requires more than 30 minutes of time spent on these activities. |
79 | $103 | $259 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
59 | $12 | $57 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $70 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $109 | $405 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $55 | $138 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
16 | $12 | $39 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
15 | $231 | $524 |
| New patient office visit, complex (60-74 min) | 14 | $119 | $523 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
13 | $58 | $152 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
11 | $176 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,138
Total received (2018-2024)
Avg $2,305/year across 7 years
Top 2% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
746
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,058 (87.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,031 (12.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,479
2023
$2,109
2022
$4,242
2021
$2,231
2020
$1,958
2019
$1,702
2018
$2,417
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$333
ABBVIE INC.
$131
Lilly USA, LLC
$112
Novo Nordisk Inc
$111
GlaxoSmithKline, LLC.
$92
Boston Scientific Corporation
$91
Seqirus USA Inc
$67
Merck Sharp & Dohme LLC
$54
Otsuka Pharmaceutical Development & Commercialization, Inc.
$49
Exact Sciences Corporation
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Astellas Pharma US Inc
$44
PFIZER INC.
$35
Amgen Inc.
$33
Otsuka America Pharmaceutical, Inc.
$30
ABIOMED
$25
Lundbeck LLC
$24
Janssen Pharmaceuticals, Inc
$23
ACADIA Pharmaceuticals Inc
$22
SI-BONE, INC.
$20
Esperion Therapeutics, Inc.
$17
Abbott Laboratories
$16
Philips North America LLC
$16
Sumitomo Pharma America, Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
CeQur Corporation
$8
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biohaven Pharmaceutical Holding Company Ltd.
$2,031
Amgen Inc.
$1,839
AstraZeneca Pharmaceuticals LP
$1,599
PFIZER INC.
$857
ABBVIE INC.
$842
GlaxoSmithKline, LLC.
$776
Novartis Pharmaceuticals Corporation
$691
Lilly USA, LLC
$664
Janssen Pharmaceuticals, Inc
$657
Novo Nordisk Inc
$521
AbbVie Inc.
$457
Bayer HealthCare Pharmaceuticals Inc.
$448
Boehringer Ingelheim Pharmaceuticals, Inc.
$340
SANOFI-AVENTIS U.S. LLC
$281
Teva Pharmaceuticals USA, Inc.
$234
Astellas Pharma US Inc
$231
Eisai Inc.
$222
Biogen, Inc.
$169
Merck Sharp & Dohme Corporation
$166
Otsuka America Pharmaceutical, Inc.
$158
Amarin Pharma Inc.
$149
Allergan, Inc.
$128
Avanir Pharmaceuticals, Inc.
$128
Seqirus USA Inc
$123
Philips Electronics North America Corporation
$122
Nevro Corp.
$121
MannKind Corporation
$117
E.R. Squibb & Sons, L.L.C.
$114
Boston Scientific Corporation
$107
Abbott Laboratories
$104
Sunovion Pharmaceuticals Inc.
$93
Mannkind Corporation
$90
ACADIA Pharmaceuticals Inc
$86
Exact Sciences Corporation
$84
Merck Sharp & Dohme LLC
$84
Zyla Life Sciences
$75
Regeneron Healthcare Solutions, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$67
Linus Health, Inc.
$55
Lundbeck LLC
$53
Tactile Systems Technology Inc
$51
Otsuka Pharmaceutical Development & Commercialization, Inc.
$49
Electromed, Inc.
$48
Sumitomo Pharma America, Inc.
$47
SI-BONE, INC.
$47
SANOFI PASTEUR INC.
$45
Bayer Healthcare Pharmaceuticals Inc.
$44
Sun Pharmaceutical Industries Inc.
$40
ARBOR PHARMACEUTICALS, INC.
$38
Esperion Therapeutics, Inc.
$30
Scilex Pharmaceuticals Inc.
$29
SI-BONE, Inc.
$26
DEXCOM, INC.
$25
Radius Health, Inc.
$25
ABIOMED
$25
Biohaven Pharmaceuticals, Inc.
$24
Alexion Pharmaceuticals, Inc.
$24
CMP Pharma, Inc.
$24
Lucid Diagnostics Inc.
$22
Sanofi Pasteur Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
IBSA Pharma Inc.
$21
Axsome Therapeutics, Inc.
$20
Genentech USA, Inc.
$20
Hologic, LLC
$18
INSYS Therapeutics Inc
$18
Ultragenyx Pharmaceutical Inc.
$18
Philips North America LLC
$16
Monaghan Medical Corporation
$15
Xeris Pharmaceuticals, Inc.
$15
TOPCON HEALTHCARE SOLUTIONS, INC.
$15
SCILEX PHARMACEUTICALS INC.
$15
AbbVie, Inc.
$15
Daiichi Sankyo Inc.
$14
Zyla Life Sciences, Inc.
$14
UCB, Inc.
$14
McKesson Medical-Surgical, Inc.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
CeQur Corporation
$8
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
(5050) Extended Holter · (CK7) Extended Holter · ADACEL · ADUHELM · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APTIMA · AREXVY · AUSTEDO · AVEIR · AVYCAZ · Aimovig · Androgel · Austedo XR · Auvelity · BAQSIMI · BELSOMRA · BREO · BREZTRI · Briviact · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONFIRM RX · CORE COGNITIVE EVALUATION · Carospir · CeQur Simplicity · Cologuard Collection Kit · DALVANCE · DEXCOM G6 TRANSMITTER · DIFICID · DRIZALMA SPRINKLE · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EZALLOR SPRINKLE · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · Flexitouch Plus · Fluad · Fluad Quadrivalent · GALLANT · GEMTESA · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · HARMONY · HUMALOG · Horizant · IFUSE IMPLANT · INJECTAFER · INVOKANA · Impella · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · LYUMJEV · Licart · MENACTRA · MITRACLIP · MOUNJARO · MYFEMBREE · MYRBETRIQ · NEXLETOL · NUCALA · NUEDEXTA · NUPLAZID · NURTEC ODT · OCTRODE · Omnia · Otezla · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Resp Care Undiv · Rybelsus · SHINGRIX · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRIX · STIOLTO RESPIMAT · SYMBICORT · SYNDROS · Senza · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VESICARE · VIIBRYD · VRAYLAR · VYNDAMAX · Vascepa · Veozah · Victoza · WATCHMAN FLX · WaveWriter Alpha Prime 16 · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN · Xofluza · ZEPBOUND · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
670
Per 100K population
20.4
County median income
$102,285
Nearest hospital
TRI-CITY MEDICAL CENTER
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Novak is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Novak experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Novak performed 2,160 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Novak receive payments from pharmaceutical companies?
Yes. Dr. Novak received a total of $16,138 from 79 companies across 746 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Novak's costs compare to other family medicine physicians in Vista?
Dr. Novak's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Novak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Vista
Browse family medicine physicians in Vista ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology